Novo Integrated Sciences EBITDA Margin 2012-2024 | NVOS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Novo Integrated Sciences (NVOS) over the last 10 years. The current EBITDA margin for Novo Integrated Sciences as of August 31, 2024 is .
| Novo Integrated Sciences EBITDA Margin Historical Data |
| Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
| 2024-08-31 |
$0.01B |
$-0.00B |
-15.38% |
| 2024-05-31 |
$0.01B |
$-0.00B |
-23.08% |
| 2024-02-29 |
$0.01B |
$-0.01B |
-38.46% |
| 2023-11-30 |
$0.01B |
$-0.00B |
-23.08% |
| 2023-08-31 |
$0.01B |
$-0.00B |
-8.33% |
| 2023-05-31 |
$0.00B |
$-0.02B |
-1600.00% |
| 2023-02-28 |
$0.01B |
$-0.01B |
-108.33% |
| 2022-11-30 |
$0.01B |
$-0.02B |
-125.00% |
| 2022-08-31 |
$0.01B |
$-0.02B |
-133.33% |
| 2022-05-31 |
$0.02B |
0 |
0.00% |
| 2022-02-28 |
$0.01B |
$-0.00B |
-18.18% |
| 2021-11-30 |
$0.01B |
$-0.00B |
-30.00% |
| 2021-08-31 |
$0.01B |
$-0.00B |
-22.22% |
| 2021-05-31 |
$0.01B |
$-0.00B |
-50.00% |
| 2021-02-28 |
$0.01B |
$-0.00B |
-57.14% |
| 2020-11-30 |
$0.01B |
$-0.00B |
-42.86% |
| 2020-08-31 |
$0.01B |
$-0.00B |
-37.50% |
| 2020-05-31 |
$0.01B |
0 |
0.00% |
| 2020-02-29 |
$0.01B |
0 |
0.00% |
| 2019-11-30 |
$0.01B |
0 |
0.00% |
| 2019-08-31 |
$0.01B |
0 |
0.00% |
| 2019-05-31 |
$0.01B |
0 |
0.00% |
| 2019-02-28 |
$0.01B |
0 |
0.00% |
| 2018-11-30 |
$0.01B |
$-0.00B |
-12.50% |
| 2018-08-31 |
$0.01B |
$-0.00B |
-12.50% |
| 2018-05-31 |
$0.01B |
$-0.00B |
-37.50% |
| 2018-02-28 |
$0.01B |
$-0.00B |
-37.50% |
| 2017-08-31 |
$0.01B |
$-0.00B |
-33.33% |
| 2016-11-30 |
$0.00B |
0 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.002B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
